Cargando…
The premise of personalized immunotherapy for cancer dormancy: Cancer dormancy vaccines
Progress in cancer therapies has resulted in improved survival of patients with early stage breast cancer. However, mortality remains high in patients with distant recurrence of the disease after initially successful treatment of early stage breast cancer. To this end, tumor recurrences have been at...
| Autor principal: | |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
2020
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7260096/ https://www.ncbi.nlm.nih.gov/pubmed/32322001 http://dx.doi.org/10.1038/s41388-020-1295-3 |